Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azar Mehr Teb Parsian is a prominent Iranian healthcare company focused on the supply and distribution of advanced medical and laboratory diagnostic equipment. Established in 2009, the firm specializes in the In-Vitro Diagnostics (IVD) market, offering a wide range of automated analyzers, reagents, and laboratory consumables. The company serves as a key intermediary, representing international biotechnology and medical device manufacturers within the Iranian market. Their product portfolio includes systems for chemiluminescence immunoassay (CLIA), biochemistry, and hematology testing. Beyond distribution, they provide comprehensive technical support, installation, and maintenance services for clinical laboratories and hospitals nationwide. The company is recognized for its role in modernizing diagnostic capabilities in the region through partnerships with global technology providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azar mehr teb parsian.